Error: Could not add to watchlist. X

Champions Oncology Inc

+ Watchlist
CSBR:US
NASDAQ CM
6.29
USD
1.29
25.80%
As of 20:10:00 ET on 08/28/2015.
Open
9.00
Day Range
5.10 - 9.00
Volume
4,898
Previous Close
5.00
52Wk Range
2.40 - 10.08
1 Yr Return
-32.80%
Open
9.00
Day Range
5.10 - 9.00
Volume
4,898
Previous Close
5.00
52Wk Range
2.40 - 10.08
1 Yr Return
-32.80%
YTD Return
4.86%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.40
Market Cap (m USD)
54.737
Shares Outstanding (m)
8.702
Price/Sales (TTM)
4.09
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Champions Oncology, Inc. develops oncology drugs. The Company implants primary human tumors in immune-deficient mice and propagates the resulting engraftments such that the biological characteristics of the original human tumor are preserved. Champions Oncology then tests oncology drugs on the engraftments.
ADDRESS
855 North Wolfe Street
Suite 619
Baltimore, MD 21205
United States
PHONE
1-410-369-0365
  • Joel Ackerman
    CEO/Secretary
  • Ronnie Morris
    President
  • Mark Weinstein
    Chief Information Officer
  • Jordan Rubinson
    Chief Commercial Officer
  • David Miller
    VP:Finance
Show More